Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026)
Emergent BioSolutions' Market Capitalization was $429.89 million in Q2 2026, up 25.5% from $342.61 million a year earlier and unchanged from the prior quarter.
Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026) Analysis & Trends
For FY2025, Market Capitalization at Emergent BioSolutions came in at $643.96 million, up 24.1% from FY2024.
- Market Capitalization shows a five-year compound annual growth rate of -33.0% (FY2020 to FY2025).
- In earlier years, Market Capitalization was $519.11 million in FY2024 (+314.4%), $125.28 million in FY2023 (-78.8%), $591.68 million in FY2022 (-73.5%) and $2.23 billion in FY2021 (-53.1%).
- Quarterly Market Capitalization has moved between $125.28 million (Q4 2023) and $2.69 billion (Q3 2021) over five years.
- Compared with a year earlier, Market Capitalization has increased for four straight quarters, with growth averaging 85.0% over the last eight quarters.
- The best year-over-year quarter for Market Capitalization over five years was Q4 2024 (growth of 314.4%); the worst was Q3 2023 (a decline of 83.2%).
- Per Business Quant data, EBS's Market Capitalization in the three quarters before Q2 2026 was $429.94 million (Q1 2026), $643.96 million (Q4 2025) and $464.81 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,145.84 Bn | 1,114.43 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 622.91 Bn | 541.44 Bn | 17.26 Bn |
| 3 | AbbVie | 510.98 Bn | 484.09 Bn | 12.70 Bn |
| 4 | Merck | 366.52 Bn | 320.90 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.50 Bn | 261.49 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn |
| 7 | Amgen | 234.77 Bn | 190.17 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn |
| 9 | Pfizer | 172.17 Bn | 118.81 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 322.24 Mn | -428.66 Mn | 137.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 429.89 Mn |
| Mar 31, 2026 | 429.94 Mn |
| Dec 31, 2025 | 643.96 Mn |
| Sep 30, 2025 | 464.81 Mn |
| Jun 30, 2025 | 342.61 Mn |
| Mar 31, 2025 | 264.87 Mn |
| Dec 31, 2024 | 519.11 Mn |
| Sep 30, 2024 | 451.74 Mn |
| Jun 30, 2024 | 360.78 Mn |
| Mar 31, 2024 | 132.57 Mn |
| Dec 31, 2023 | 125.28 Mn |
| Sep 30, 2023 | 176.12 Mn |
| Jun 30, 2023 | 380.73 Mn |
| Mar 31, 2023 | 522.14 Mn |
| Dec 31, 2022 | 591.68 Mn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Mar 31, 2022 | 2.07 Bn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 2.69 Bn |
Emergent BioSolutions Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();